Greenwich Lifesciences Inc expected to post a loss of 20 cents a share - Earnings Preview

Greenwich Lifesciences

12/04/2024 21:10

* Greenwich Lifesciences Inc  GLSI.OQ   GLSI.O  is expected
to show no change in quarterly revenue when it reports 
results on April 16 (estimated) for the period ending December
31 2023
    * 
    * ​LSEG's mean analyst estimate for Greenwich Lifesciences
Inc is
for a loss of 20 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The average consensus recommendation for
the pharmaceuticals
peer group is also "Buy".​
    * Wall Street's median 12-month price target for Greenwich
Lifesciences Inc is $36.00​, above​ its last closing price
of $16.06. ​​​

This summary was machine generated April 12 at 20:10 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)